ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

CD19xCD3 T cell engager blinatumomab effective in refractory generalized myasthenic syndromes.

Tobias Ruck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.